Literature DB >> 18514187

Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory.

Reeteka Sud1, Robert N Spengler, Nader D Nader, Tracey A Ignatowski.   

Abstract

Tumor necrosis factor-alpha (TNF) plays a role in neuropathic pain. During neuropathic pain development in the chronic constriction injury model, elevated TNF levels in the brain occur in association with enhanced alpha 2-adrenoceptor inhibition of norepinephrine release. alpha 2-Adrenoceptors are also located on peripheral macrophage where they normally function as pro-inflammatory, since they increase the production of the cytokine TNF, a proximal mediator of inflammation. How the central increase in TNF affects peripheral alpha 2-adrenoceptor function was investigated. Male, Sprague-Dawley rats had four loose ligatures placed around the right sciatic nerve. Thermal hyperalgesia was determined by comparing hind paw withdrawal latencies between chronic constriction injury and sham-operated rats. Chronic constriction injury increased TNF immunoreactivity at the lesion and the hippocampus. Amitriptyline, an antidepressant that is used as an analgesic, was intraperitoneally administered (10 mg/kg) starting simultaneous with ligature placement (day-0) or at days-4 or -6 post-surgery. Amitriptyline treatment initiated at day-0 or day-4 post-ligature placement alleviated hyperalgesia. When initiated at day-0, amitriptyline prevented increased TNF immunoreactivity in the hippocampus and at the lesion. A peripheral inflammatory response, macrophage production of TNF, was also assessed in the current study. Lipopolysaccharide (LPS)-stimulated production of TNF by whole blood cells and peritoneal macrophages was determined following activation of the alpha 2-adrenoceptor in vitro. alpha 2-Adrenoceptor regulation of TNF production from peripheral immune-effector cells reversed from potentiation in controls to inhibition in chronic constriction injured rats. This effect is accelerated with amitriptyline treatment initiated at day-0 or day-4 post-ligature placement. Amitriptyline treatment initiated day-6 post-ligature placement did not alleviate hyperalgesia and prevented the switch from potentiation to inhibition in alpha 2-adrenoceptor regulation of TNF production. Recombinant rat TNF i.c.v. microinfusion reproduces the response of peripheral macrophages from rats with chronic constriction injury. A reversal in peripheral alpha 2-adrenoceptor regulation of TNF production from pro- to anti-inflammatory is associated with effective alleviation of thermal hyperalgesia. Thus, alpha 2-adrenoceptor regulation of peripheral TNF production may serve as a potential biomarker to evaluate therapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514187      PMCID: PMC2587399          DOI: 10.1016/j.ejphar.2008.04.043

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  95 in total

1.  Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine.

Authors:  J Sawynok; A R Reid; M J Esser
Journal:  Pain       Date:  1999-03       Impact factor: 6.961

2.  Adrenergic regulation of macrophage-derived tumor necrosis factor-alpha generation during a chronic polyarthritis pain model.

Authors:  R C Chou; X L Dong; B K Noble; P R Knight; R N Spengler
Journal:  J Neuroimmunol       Date:  1998-03-01       Impact factor: 3.478

3.  Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres.

Authors:  L S Sorkin; W H Xiao; R Wagner; R R Myers
Journal:  Neuroscience       Date:  1997-11       Impact factor: 3.590

4.  Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.

Authors:  M Maes; C Song; A H Lin; S Bonaccorso; G Kenis; R De Jongh; E Bosmans; S Scharpé
Journal:  Neuropsychopharmacology       Date:  1999-04       Impact factor: 7.853

5.  Analgesic effect of antidepressant drugs.

Authors:  I Korzeniewska-Rybicka; A Płaźnik
Journal:  Pharmacol Biochem Behav       Date:  1998-02       Impact factor: 3.533

6.  Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects.

Authors:  M J Esser; J Sawynok
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

7.  Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity.

Authors:  C Sommer; M Schäfers
Journal:  Brain Res       Date:  1998-02-16       Impact factor: 3.252

8.  The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve.

Authors:  Claudia Sommer; Martin Marziniak; Robert R Myers
Journal:  Pain       Date:  1998-01       Impact factor: 6.961

9.  Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration.

Authors:  T A Ignatowski; B K Noble; J R Wright; J L Gorfien; R R Heffner; R N Spengler
Journal:  J Neuroimmunol       Date:  1997-10       Impact factor: 3.478

10.  Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.

Authors:  S H Richeimer; Z H Bajwa; S S Kahraman; B J Ransil; C A Warfield
Journal:  Clin J Pain       Date:  1997-12       Impact factor: 3.442

View more
  8 in total

1.  Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor.

Authors:  Elizabeth Gerard; Robert N Spengler; Adela C Bonoiu; Supriya D Mahajan; Bruce A Davidson; Hong Ding; Rajiv Kumar; Paras N Prasad; Paul R Knight; Tracey A Ignatowski
Journal:  Pain       Date:  2015-07       Impact factor: 7.926

2.  Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis.

Authors:  Dominique Muschter; Claudia Göttl; Mandy Vogel; Joachim Grifka; Rainer H Straub; Susanne Grässel
Journal:  Arthritis Res Ther       Date:  2015-06-24       Impact factor: 5.156

3.  The arginine decarboxylase pathways of host and pathogen interact to impact inflammatory pathways in the lung.

Authors:  Nick B Paulson; Adam J Gilbertsen; Joseph J Dalluge; Cole W Welchlin; John Hughes; Wei Han; Timothy S Blackwell; Theresa A Laguna; Bryan J Williams
Journal:  PLoS One       Date:  2014-10-28       Impact factor: 3.240

4.  Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23.

Authors:  Gong Chen; Yuan Le; Lei Zhou; Li Gong; Xiaoxiao Li; Yunli Li; Qin Liao; Kaiming Duan; Jianbin Tong; Wen Ouyang
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  Quantification of horse plasma proteins altered by xylazine using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry.

Authors:  Miwako Mori; Tomoko Ichibangase; Shozo Yamashita; Isao Kijima-Suda; Masahiro Kawahara; Kazuhiro Imai
Journal:  J Equine Sci       Date:  2016-02-03

6.  Gingerol-Enriched Ginger Supplementation Mitigates Neuropathic Pain via Mitigating Intestinal Permeability and Neuroinflammation: Gut-Brain Connection.

Authors:  Chwan-Li Shen; Rui Wang; Vadim Yakhnitsa; Julianna Maria Santos; Carina Watson; Takaki Kiritoshi; Guangchen Ji; Abdul Naji Hamood; Volker Neugebauer
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

7.  Sedation improves early outcome in severely septic Sprague Dawley rats.

Authors:  Hong Qiao; Robert D Sanders; Daqing Ma; Xinmin Wu; Mervyn Maze
Journal:  Crit Care       Date:  2009-08-19       Impact factor: 9.097

8.  Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial.

Authors:  Yan Liu; Jiaxin Sun; Tong Wu; Xiaoying Lu; Yueyao Du; Hongwei Duan; Weifeng Yu; Diansan Su; Jinsong Lu; Jie Tian
Journal:  Cancer Med       Date:  2019-10-30       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.